Brief: Bioarctic says Long-Term Lecanemab Data Show Increased Patient Benefit With Maintained Safety Profile
30/07/2024 22:01
July 30 (Reuters) - BioArctic AB BIOAb.ST :
* LONG-TERM LECANEMAB DATA SHOW INCREASED PATIENT BENEFIT
WITH
MAINTAINED SAFETY PROFILE
Source text for Eikon: ID:nWkr1bJbMK
Further company coverage: BIOAb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million